Patents by Inventor Alan McClelland

Alan McClelland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8100510
    Abstract: An inkjet nozzle array includes a plurality of nozzles. Each nozzle includes a chamber having an input aperture adapted to receive ink into the chamber and an output aperture through which ink is ejected from the chamber. Each chamber further includes a window adapted to receive electromagnetic radiation and operable to heat ink in the chamber responsive to the electromagnetic radiation and eject an ink droplet through the output aperture.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 24, 2012
    Assignee: Marvell International Technology Ltd.
    Inventors: Gregory Frank Carlson, Ronald Gregory Paul, Steven Michael Goss, Todd Alan McClelland
  • Publication number: 20110043571
    Abstract: An inkjet nozzle array includes a plurality of nozzles. Each nozzle includes a chamber having an input aperture adapted to receive ink into the chamber and an output aperture through which ink is ejected from the chamber. Each chamber further includes a window adapted to receive electromagnetic radiation and operable to heat ink in the chamber responsive to the electromagnetic radiation and eject an ink droplet through the output aperture.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Inventors: Gregory Frank Carlson, Ronald Gregory Paul, Steven Michael Goss, Todd Alan McClelland
  • Patent number: 7837302
    Abstract: An inkjet nozzle array includes a plurality of nozzles. Each nozzle includes a chamber having an input aperture adapted to receive ink into the chamber and an output aperture through which ink is ejected from the chamber. Each chamber further includes a window adapted to receive electromagnetic radiation and operable to heat ink in the chamber responsive to the electromagnetic radiation and eject an ink droplet through the output aperture.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: November 23, 2010
    Assignee: Marvell International Technology Ltd.
    Inventors: Gregory Frank Carlson, Ronald Gregory Paul, Steven Michael Goss, Todd Alan McClelland
  • Patent number: 7517039
    Abstract: The velocity of a printhead scanning across a sheet of paper or other print medium is varied on the basis of whether masking patterns for selectively activating nozzle of the printhead include activations in consecutive pixel locations of the masking pattern. The pixel locations are “firing opportunities” as defined by the maximum firing frequency assigned to the nozzles when the printhead is scanned at a particular velocity. The printhead is moved at that velocity when a masking pattern includes activation in consecutive pixel locations. On the other hand, a higher scanning velocity is available when a constraint is enforced to prevent occasions of firings in consecutive pixel locations. In one embodiment, the constraint is not enforced, but masking patterns are analyzed on a pattern-by-pattern basis to detect those patterns which satisfy the constraint, so that the scanning velocity can be increased during the suitable masking patterns.
    Type: Grant
    Filed: September 19, 2005
    Date of Patent: April 14, 2009
    Assignee: Marvell International Technology Ltd.
    Inventors: Todd Alan McClelland, Gregory Frank Carlson, Ronald Gregory Paul, Steven Michael Goss, Randall Lee Stockberger
  • Patent number: 7265803
    Abstract: A circuit sheet comprising a substrate and wells dispersed on the substrate operable to hold conductive polymers that form circuit devices.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: September 4, 2007
    Assignee: Avago Technologies General IP (Singapore) Pte. Ltd.
    Inventors: Gregory Frank Carlson, Todd Alan McClelland, Patrick Alan McKinley
  • Patent number: 7253580
    Abstract: A different adaptive control method is used to control a motor during each of two or more phases of motor operation. Thus, in a first phase of motor operation the motor is controlled using a first adaptive control method, in a second phase of motor operation the motor is controlled using a second adaptive control method, and so forth. The motor can be controlled in this manner in any number of phases, in which the motor is used for any of a number of corresponding purposes. The method used in each phase can be optimized to suit that type of operation without compromising operation during other phases.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: August 7, 2007
    Assignee: Marvell International Technology Ltd.
    Inventors: Randall Lee Stockberger, Ronald Gregory Paul, Todd Alan McClelland, Gregory Frank Carlson
  • Patent number: 7202302
    Abstract: Polyisocyanurate systems, pultrusion of those systems to produce reinforced polyisocyanurate matrix composites, and to composites produced thereby. The polyisocyanurate systems include a polyol component, an optional chain extender, and an isocyanate. The polyisocyanurate systems have extended initiation times of about 5 minutes to about 30 minutes at room temperature, and can be snap cured.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: April 10, 2007
    Assignee: Huntsman International LLC
    Inventors: Evan H. Cheolas, Berend Eling, Ravi R. Joshi, Alan McClelland, Ajay Padsalgikar, Andreas H. Rothacker
  • Patent number: 7132395
    Abstract: Method of inhibiting human rhinovirus (HRV) Infection by contacting said HRV with a polypeptide comprising a fragment of human rhinovirus major receptor (HRR), said fragment comprising the HRV binding site and being selected from a specific group consisting of HRR domains.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: November 7, 2006
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Jeffrey M. Greve, Alan McClelland, Gary Davis
  • Patent number: 6931259
    Abstract: The present invention is an integrated system on a chip that combines wireless, graphics, and multimedia. The graphics and multimedia features may be programmed by the end user while restricting programmability of the wireless features.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: August 16, 2005
    Assignee: Agilnet Technologies, Inc.
    Inventors: Laura E Simmons, James Daren Bledsoe, Daniel I Croft, Patrick A. McKinley, Gregory Frank Carlson, Ignacio Jose Perez, Paul Anthony Chenard, Raymond Jensen Hasler, Shelly Rose Reasoner, Todd Alan McClelland, Thomas P. Bruch
  • Publication number: 20040175364
    Abstract: A method of transferring at least one DNA sequence into cells by transducing the cells, in vivo or ex vivo, with a modified adenovirus. The adenovirus, prior to modification, is of a first serotype. In the modified adenovirus, at least a portion of the fiber, and in particular the head portion, is removed from the adenovirus of the first serotype and replaced with a portion, in particular the head portion, of the fiber of an adenovirus of a second serotype. Such method is useful in transducing cells which may be refractory to the adenovirus of the first serotype, yet include a receptor which binds to the head portion of the fiber of the adenovirus of the second serotype.
    Type: Application
    Filed: April 1, 2004
    Publication date: September 9, 2004
    Inventors: Alan McClelland, Susan C. Stevenson, Mario Gorziglia, Elio F. Vanin
  • Publication number: 20040094859
    Abstract: Polyisocyanurate systems, pultrusion of those systems to produce reinforced polyisocyanurate matrix composites, and to composites produced thereby. The polyisocyanurate systems include a polyol component, an optional chain extender, and an isocyanate. The polyisocyanurate systems have extended initiation times of about 5 minutes to about 30 minutes at room temperature, and can be snap cured.
    Type: Application
    Filed: November 17, 2003
    Publication date: May 20, 2004
    Inventors: Evan H. Cheolas, Berend Eling, Ravi R. Joshi, Alan McClelland, Ajay Padsalgikar, Andreas H. Rothacker
  • Publication number: 20030147853
    Abstract: Methods for introducing recombinant adeno-associated virus (rAAV) virions into a cell or cells of a secretory gland are described. Recombinant AAV virions containing a heterologous gene are introduced into a duct of a secretory gland resulting in transduction of one or more secretory gland cells. Once a secretory gland cell is transduced by the rAAV virion, the heterologous gene is expressed and the expression product is then secreted. Exemplary examples of secretory glands are the liver, the submandibular gland, the parotid gland, and the sublingual gland. Using the methods of the invention, therapeutic levels of a protein are achieved. Methods for treating hemophilia are also disclosed.
    Type: Application
    Filed: March 14, 2002
    Publication date: August 7, 2003
    Inventors: Alan McClelland, Roland Scollay
  • Publication number: 20030143236
    Abstract: The present invention relates to novel forms and configurations of intercellular adhesion molecule (ICAM) including multimeric configurations that effectively bind to human rhinovirus and can effectively reduce HRV infectivity. When in a multimeric configuration, preferably as dimers, these proteins display enhanced binding of HRV and are able to reduce HRV infectivity as well as the infectivity of other viruses known to bind to the “major” group human rhinovirus receptor (HRR). The multimerized proteins may also be used to block tICAM interaction with lymphocyte function-associated antigen-1 (LFA-1).
    Type: Application
    Filed: June 5, 1995
    Publication date: July 31, 2003
    Inventors: JEFFREY M. GREVE, ALAN MCCLELLAND
  • Publication number: 20030064747
    Abstract: The present invention is an integrated system on a chip that combines wireless, graphics, and multimedia. The graphics and multimedia features may be programmed by the end user while restricting programmability of the wireless features.
    Type: Application
    Filed: October 2, 2001
    Publication date: April 3, 2003
    Inventors: Laura E. Simmons, James Daren Bledsoe, Daniel I. Croft, Patrick A. McKinley, Gregory Frank Carlson, Ignacio Jose Perez, Paul Anthony Chenard, Raymond Jensen Hasler, Shelly Rose Reasoner, Todd Alan McClelland, Thomas P. Bruch
  • Patent number: 6514936
    Abstract: A method for substantially inhibiting initiation or spread of infection by rhinovirus or Coxsackie A virus of host cells expressing the major human rhinovirus receptor (ICAM-1), comprising the step of contacting the virus with a soluble polypeptide comprising the HRV binding site in domains I and II of ICAM-1; which polypeptide is capable of binding to the virus and reducing infectivity thereof; the contact being under conditions which permit the virus to bind to the polypeptide.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: February 4, 2003
    Assignee: Bayer Corporation
    Inventors: Jeffrey M. Greve, Alan McClelland, Gary Davis
  • Publication number: 20020192187
    Abstract: A method of transferring at least one DNA sequence into cells by transducing the cells, in vivo or ex vivo, with a modified adenovirus. The adenovirus, prior to modification, is of a first serotype. In the modified adenovirus, at least a portion of the fiber, and in particular the head portion, is removed from the adenovirus of the first serotype and replaced with a portion, in particular the head portion, of the fiber of an adenovirus of a second serotype. Such method is useful in transducing cells which may be refractory to the adenovirus of the first serotype, yet include a receptor which binds to the head portion of the fiber of the adenovirus of the second serotype.
    Type: Application
    Filed: March 11, 2002
    Publication date: December 19, 2002
    Inventors: Alan McClelland, Susan C. Stevenson, Mario Gorziglia, Elio F. Vanin
  • Publication number: 20020123147
    Abstract: A method of transferring at least one DNA sequence into cells by transducing the cells, in vivo or ex vivo, with a modified adenovirus. The adenovirus, prior to modification, is of a first serotype. In the modified adenovirus, at least a portion of the fiber, and in particular the head portion, is removed from the adenovirus of the first serotype and replaced with a portion, in particular the head portion, of the fiber of an adenovirus of a second serotype. Such method is useful in transducing cells which may be refractory to the adenovirus of the first serotype, yet include a receptor which binds to the head portion of the fiber of the adenovirus of the second serotype.
    Type: Application
    Filed: November 27, 2001
    Publication date: September 5, 2002
    Applicant: GENETIC THERAPY, INC.
    Inventors: Alan McClelland, Susan C. Stevenson, Mario Gorziglia, Elio F. Vanin
  • Patent number: 6326004
    Abstract: Antiviral methods comprising contacting human rhinovirus with tICAM(453).
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: December 4, 2001
    Assignee: Bayer Corporation
    Inventors: Jeffrey M. Greve, Alan McClelland, Gary Davis
  • Patent number: 6143298
    Abstract: Novel analogs of ICAM-1 and methods of using same for reducing human rhinovirus infection.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: November 7, 2000
    Assignee: Bayer Corporation
    Inventors: Jeffrey M. Greve, Alan McClelland, Gary Davis
  • Patent number: 6130202
    Abstract: Methods for inhibiting infectivity and reducing infection by human rhinovirus (HRV) of host cells susceptible to infection by HRV and methods of inhibiting initiation and spread of the common cold, said methods comprising contacting HRV under conditions favorable for binding with a multimeric antiviral agent comprising two or more units wherein said units may be the same or different and are each independently selected from the group consisting of transmembrane intercellular adhesion molecule-1 (tmICAM-1) and truncated forms of intercellular adhesion molecule-1 (tICAMs), each of said units containing at least one unpaired cysteine residue at a position selected from the group consisting of 307 and 309, wherein each of said units is linked to at least one other of said units via a disulfide bridge, and wherein said multimeric antiviral agent binds to HRV and reduces infectivity thereof.
    Type: Grant
    Filed: April 14, 1994
    Date of Patent: October 10, 2000
    Assignee: Bayer Corporation
    Inventors: Jeffrey M. Greve, Alan McClelland